- Easy Tracking In The Watchlist
Larimar Therapeutics, Inc. stock downgraded to Sell Candidate
(Updated on Jun 25, 2026)
The Larimar Therapeutics, Inc. stock price fell by -3.58% on the last day (Thursday, 25th Jun 2026) from $3.63 to $3.50. During the last trading day the stock fluctuated 8.60% from a day low at $3.49 to a day high of $3.79. The price has risen in 6 of the last 10 days and is up by 1.74% over the past 2 weeks. Volume has increased on the last day by 195 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $6.14 million.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.62 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -33.17% during the next 3 months and, with a 90% probability hold a price between $1.84 and $2.42 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
LRMR Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 12.90%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Larimar Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $3.58 and $3.58. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Larimar Therapeutics, Inc. stock
Larimar Therapeutics, Inc. finds support from accumulated volume at $3.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.300 between high and low, or 8.60%. For the last week, the stock has had daily average volatility of 6.49%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LRMR) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Larimar Therapeutics, Inc. to open at $3.59, and during the day (based on 14 day Average True Range), to move between $3.38 and $3.62, which gives a possible trading interval of +/-$0.243 (+/-7.18%) up or down from last closing price. If Larimar Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.18% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.47 (0.86%) than the resistance at $3.58 (2.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Larimar Therapeutics, Inc. stock A Buy?
Larimar Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score:
-2.249
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 26, 2026 - $3.59 ( 2.67%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LRMR Performance
Trading levels for LRMR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.89 | 11.24% |
| R2 | 3.78 | 7.96% |
| R1 | 3.71 | 5.94% |
| Price | 3.50 | |
| S1 | 3.48 | -0.608% |
| S2 | 3.41 | -2.63% |
| S3 | 3.29 | -5.90% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.89 | 11.14% |
| R2 | 3.60 | 2.86% |
| R1 | 3.58 | 2.29% |
| Price | 3.50 | |
| S1 | 3.47 | -0.86% |
| S2 | 3.44 | -1.71% |
| S3 | 3.24 | -7.43% |
FAQ
Click here for our free guide on how to buy Larimar Therapeutics, Inc. Stock.
Buy LRMR